Fabros Returns to Profitability After Major Losses in 2024
Fabros Pharmaceutical Company announced a net profit of <strong>27.44 billion Indonesian rupiah</strong> in 2025, recovering from a loss of <strong>290.63 billion rupiah</strong> the previous year. This positive turnaround is attributed to a <strong>26.34%</strong> increase in sales.